@article{2b75816a220d499ba70893e535b4b2ec,
title = "Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis",
author = "Mowry, {Ellen M.} and Corboy, {John R.}",
note = "Funding Information: EMM reports serving as site principal investigator for clinical trials or studies sponsored by Biogen and SunPharma; research support from Sanofi Genzyme and Biogen for investigator-initiated trials; free medication for a clinical trial, of which she is principal investigator, from Teva Neuroscience; and royalties for editorial duties from UpToDate. JRC reports grants from MedDay, Novartis, the Patient Centered Outcomes Research Institute (also as coordinating center), and the National Multiple Sclerosis Society; and personal fees from Mylan, Prime Continuing Medical Education, Medical Logix, and the American Academy of Neurology.",
year = "2019",
month = nov,
doi = "10.1016/S1474-4422(19)30333-3",
language = "English (US)",
volume = "18",
pages = "983--985",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "11",
}